Balchem Corporation (NASDAQ:BCPC) Stake Increased by Geneva Capital Management LLC

Geneva Capital Management LLC grew its stake in Balchem Corporation (NASDAQ:BCPC - Free Report) by 1.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 830,813 shares of the basic materials company's stock after purchasing an additional 11,067 shares during the period. Balchem makes up about 2.6% of Geneva Capital Management LLC's holdings, making the stock its 9th largest holding. Geneva Capital Management LLC owned approximately 2.55% of Balchem worth $137,915,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in BCPC. Quadrant Capital Group LLC lifted its holdings in Balchem by 8.2% during the 4th quarter. Quadrant Capital Group LLC now owns 989 shares of the basic materials company's stock worth $161,000 after buying an additional 75 shares in the last quarter. Covestor Ltd boosted its holdings in Balchem by 93.8% in the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock valued at $26,000 after purchasing an additional 76 shares during the period. Vident Advisory LLC grew its stake in Balchem by 6.0% during the 4th quarter. Vident Advisory LLC now owns 1,421 shares of the basic materials company's stock worth $232,000 after purchasing an additional 80 shares in the last quarter. Mackenzie Financial Corp increased its holdings in Balchem by 2.2% during the 4th quarter. Mackenzie Financial Corp now owns 3,840 shares of the basic materials company's stock worth $626,000 after purchasing an additional 84 shares during the period. Finally, Heritage Family Offices LLP raised its position in Balchem by 5.9% in the 1st quarter. Heritage Family Offices LLP now owns 1,504 shares of the basic materials company's stock valued at $250,000 after purchasing an additional 84 shares in the last quarter. Hedge funds and other institutional investors own 87.91% of the company's stock.

Balchem Stock Down 1.0%

BCPC stock traded down $1.59 during midday trading on Thursday, reaching $158.41. 104,542 shares of the company were exchanged, compared to its average volume of 167,385. The stock's 50-day simple moving average is $159.43 and its 200 day simple moving average is $162.16. Balchem Corporation has a 1-year low of $145.70 and a 1-year high of $185.96. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.57 and a current ratio of 2.64. The company has a market cap of $5.14 billion, a price-to-earnings ratio of 36.35, a price-to-earnings-growth ratio of 3.34 and a beta of 0.88.

Balchem (NASDAQ:BCPC - Get Free Report) last announced its earnings results on Thursday, July 31st. The basic materials company reported $1.27 EPS for the quarter, beating analysts' consensus estimates of $1.25 by $0.02. Balchem had a net margin of 14.48% and a return on equity of 12.41%. The business had revenue of $255.47 million for the quarter, compared to analysts' expectations of $250.31 million. During the same period in the previous year, the company posted $1.09 EPS. The company's quarterly revenue was up 9.1% on a year-over-year basis. On average, equities analysts forecast that Balchem Corporation will post 4.64 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. HC Wainwright upped their target price on shares of Balchem from $180.00 to $189.00 and gave the stock a "buy" rating in a research note on Monday. Wall Street Zen downgraded shares of Balchem from a "buy" rating to a "hold" rating in a research note on Saturday, July 26th.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.